D-0777-2023 Class II Terminated

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA drug recall D-0777-2023 was initiated by Fresenius Medical Care Holdings, Inc. on May 23, 2023 and is designated Class II. Reason for recall: Lack of assurance of sterility: The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging. The recall status is terminated (terminated May 23, 2024). Affected quantity: 53,424 bags.

Recall details

Product Type
Drugs
Report Date
Jun 7, 2023
Initiation Date
May 23, 2023
Termination Date
May 23, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
53,424 bags

Product description

Sodium Chloride 0.9% Injection, USP, 1000 mL bags, 12 bags per carton, Rx only, Fresenius Medical Care North America, Waltham, MA 02451, NDC # 49230-300-10

Reason for recall

Lack of assurance of sterility: The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging.

Distribution pattern

Product was distributed to 32 clinics in SC, NC and VA.

Code information

Lot # 23AU05030, Exp 01/13/2024; 23AU05035, Exp 01/15/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0777-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0777-2023. Report a data issue: hello@regdatalab.com.